https://www.corporateprofile.com/ 2019-01-30T20:31:17+00:00 1.0000 https://www.corporateprofile.com/feed/ 2026-09-27T04:13:29+00:00 0.8000 https://www.corporateprofile.com/comments/feed/ 2026-09-27T04:13:29+00:00 0.8000 https://www.corporateprofile.com/home/feed/ 2026-09-27T04:13:29+00:00 0.8000 https://www.corporateprofile.com/about/ 2021-03-01T18:16:07+00:00 0.8000 https://www.corporateprofile.com/media/ 2019-01-24T12:16:51+00:00 0.8000 https://www.corporateprofile.com/contact/ 2019-01-31T15:26:06+00:00 0.8000 https://www.corporateprofile.com/about/disclaimer/ 2019-01-22T17:28:09+00:00 0.8000 https://www.corporateprofile.com/about/feed/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/media/feed/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/2023/08/04/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/category/finance/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/category/videos/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/2023/08/04/brenmiller-signs-memorandum-of-understanding-with-indias-largest-solarpanel-manufacturer/ 2023-08-04T20:48:39+00:00 0.6400 https://www.corporateprofile.com/2023/08/04/cel-sci-advances-regulatory-approval-for-multikine/ 2023-08-04T19:00:42+00:00 0.6400 https://www.corporateprofile.com/2023/08/04/mobilicom-expands-into-new-geographic-markets/ 2023-08-04T18:08:07+00:00 0.6400 https://www.corporateprofile.com/2023/08/04/u-s-national-institutes-of-health-to-fund-4-2-million-contract-to-advance-pluris-plx-r18/ 2023-08-04T17:39:18+00:00 0.6400 https://www.corporateprofile.com/2019/10/03/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/category/people/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/2019/10/03/single-rider-vehicles-could-be-the-future-of-urban-transportation/ 2019-10-03T19:54:12+00:00 0.6400 https://www.corporateprofile.com/2019/03/26/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/2019/03/26/oramed-protein-oral-delivery-technology-nasdaq-ormp-french-language/ 2019-03-26T20:02:01+00:00 0.6400 https://www.corporateprofile.com/2019/03/12/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/category/entertainment/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/2019/03/12/nyc-bars-that-are-all-fun-and-games/ 2019-03-12T20:17:04+00:00 0.6400 https://www.corporateprofile.com/2018/11/06/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/category/popular/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/2018/11/06/what-its-like-to-run-away-with-the-big-apple-circus/ 2018-11-06T17:34:00+00:00 0.6400 https://www.corporateprofile.com/2018/10/05/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/2018/10/05/test-driving-las-drive-thru-haunted-houses/ 2023-07-31T19:48:31+00:00 0.6400 https://www.corporateprofile.com/2018/06/08/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/2018/06/08/competitive-eater-vs-most-expensive-sundae-burger-in-nyc-1-3k-challenge-at-serendipity-3/ 2018-06-08T19:47:57+00:00 0.6400 https://www.corporateprofile.com/category/uncategorized/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/contact/feed/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/about/disclaimer/feed/ 2026-09-27T04:13:29+00:00 0.6400 https://www.corporateprofile.com/author/admin/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/category/finance/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2018/05/30/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2018/05/30/wize-pharma-hopes-to-shake-up-3-7b-rx-eye-drop-market/ 2018-05-30T22:31:30+00:00 0.5120 https://www.corporateprofile.com/2017/11/17/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2017/11/17/oramed-receives-approval-to-conduct-clinical-study-for-treatment-of-nash-w-oral-insulin/ 2017-11-18T01:18:06+00:00 0.5120 https://www.corporateprofile.com/2017/06/05/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2017/06/05/psti-critical-limb-ischemia-phase-iii-trial-cleared-in-the-us-uk-and-germany/ 2017-10-13T17:54:04+00:00 0.5120 https://www.corporateprofile.com/2017/06/05/canf-commencing-patient-recruitment-for-phase-iii-trial-of-piclidenoson/ 2017-06-05T19:28:23+00:00 0.5120 https://www.corporateprofile.com/category/videos/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2023/08/04/brenmiller-signs-memorandum-of-understanding-with-indias-largest-solarpanel-manufacturer/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2023/08/04/cel-sci-advances-regulatory-approval-for-multikine/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2023/08/04/mobilicom-expands-into-new-geographic-markets/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2023/08/04/u-s-national-institutes-of-health-to-fund-4-2-million-contract-to-advance-pluris-plx-r18/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/category/people/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2018/05/30/the-race-to-bring-the-first-oral-insulin-capsule-to-market/ 2018-05-30T22:17:37+00:00 0.5120 https://www.corporateprofile.com/2018/04/05/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2018/04/05/the-rise-of-smart-cities-understanding-the-future-of-connected-living/ 2018-04-05T20:09:52+00:00 0.5120 https://www.corporateprofile.com/2018/02/05/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2018/02/05/virtual-measurement-app-aims-to-disrupt-online-apparel-market/ 2018-02-05T17:41:40+00:00 0.5120 https://www.corporateprofile.com/2016/12/15/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2016/12/15/special-report-cashless-society-contactless-payments/ 2017-10-13T17:53:44+00:00 0.5120 https://www.corporateprofile.com/2015/12/14/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2015/12/14/the-changing-face-of-transgender-surgery/ 2015-12-14T20:55:04+00:00 0.5120 https://www.corporateprofile.com/2015/08/10/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2015/08/10/interview-with-anne-marie-martinez-a-m-i-lifestyle-creation-agency/ 2015-08-11T00:34:39+00:00 0.5120 https://www.corporateprofile.com/2015/07/02/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2015/07/02/ultra-runner-author-david-clark-talks-running-recovery-the-boston-marathon/ 2015-07-02T16:36:12+00:00 0.5120 https://www.corporateprofile.com/2015/05/14/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2015/05/14/pluristem-ceo-zami-aberman-psti-entering-japans-accelerated-pathway-for-regenerative-medicine/ 2015-05-14T21:33:05+00:00 0.5120 https://www.corporateprofile.com/2019/10/03/single-rider-vehicles-could-be-the-future-of-urban-transportation/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2019/03/26/oramed-protein-oral-delivery-technology-nasdaq-ormp-french-language/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/category/entertainment/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2018/03/05/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2018/03/05/this-nyc-bakery-can-turn-your-face-into-a-cookie/ 2018-03-05T18:39:51+00:00 0.5120 https://www.corporateprofile.com/2017/12/01/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2017/12/01/virtual-tour-of-louis-vuittons-volez-voguez-voyagez-nyc-exhibition/ 2017-12-01T15:54:45+00:00 0.5120 https://www.corporateprofile.com/2017/11/17/behind-the-scenes-of-the-macys-thanksgiving-day-parade-2017/ 2017-11-17T17:01:59+00:00 0.5120 https://www.corporateprofile.com/2017/10/13/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2017/10/13/next-level-nyc-movie-theaters-the-nyc-urban-guidebook/ 2017-10-13T17:13:49+00:00 0.5120 https://www.corporateprofile.com/2017/08/14/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2017/08/14/us-open-ballperson-making-the-cut/ 2017-08-14T21:21:43+00:00 0.5120 https://www.corporateprofile.com/2017/05/30/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2017/05/30/print-yourself-in-3d-doob-custom-action-figures/ 2017-05-30T17:55:13+00:00 0.5120 https://www.corporateprofile.com/2019/03/12/nyc-bars-that-are-all-fun-and-games/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/category/popular/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2017/02/06/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2017/02/06/backstage-pass-to-the-rolling-stones-exhibit-w-curator-ileen-gallagher/ 2017-02-06T20:30:58+00:00 0.5120 https://www.corporateprofile.com/2016/11/21/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2016/11/21/the-past-present-and-future-of-neon-in-new-york-w-let-there-be-neon/ 2016-11-21T19:45:25+00:00 0.5120 https://www.corporateprofile.com/2016/08/31/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2016/08/31/nycs-most-instagrammable-foods-the-new-class/ 2016-08-31T18:42:47+00:00 0.5120 https://www.corporateprofile.com/2016/07/05/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2016/07/05/discover-the-nyc-street-art-scene-w-urban-art-expert-gabe-schoenberg-graff-tours/ 2016-07-05T19:45:25+00:00 0.5120 https://www.corporateprofile.com/2016/05/25/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2016/05/25/the-story-of-janes-carousel-interview-w-jane-walentas/ 2016-05-25T18:11:17+00:00 0.5120 https://www.corporateprofile.com/2016/04/11/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2016/04/11/eggloos-egg-waffle-ice-cream-cones-are-nycs-newest-dessert-craze/ 2016-04-11T17:38:17+00:00 0.5120 https://www.corporateprofile.com/2018/11/06/what-its-like-to-run-away-with-the-big-apple-circus/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2018/10/05/test-driving-las-drive-thru-haunted-houses/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2018/06/08/competitive-eater-vs-most-expensive-sundae-burger-in-nyc-1-3k-challenge-at-serendipity-3/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/category/uncategorized/feed/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2015/05/14/labstyle-innovations-receives-health-canada-approval-for-commercialization-of-the-dario/ 2015-05-14T21:21:42+00:00 0.5120 https://www.corporateprofile.com/2014/11/25/ 2026-09-27T04:13:29+00:00 0.5120 https://www.corporateprofile.com/2014/11/25/oramed-company-overview-nasdaq-ormp-russian-language-2/ 2014-11-25T20:48:03+00:00 0.5120 https://www.corporateprofile.com/author/admin/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2018/05/30/wize-pharma-hopes-to-shake-up-3-7b-rx-eye-drop-market/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2017/11/17/oramed-receives-approval-to-conduct-clinical-study-for-treatment-of-nash-w-oral-insulin/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2017/06/05/psti-critical-limb-ischemia-phase-iii-trial-cleared-in-the-us-uk-and-germany/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2017/06/05/canf-commencing-patient-recruitment-for-phase-iii-trial-of-piclidenoson/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2018/05/30/the-race-to-bring-the-first-oral-insulin-capsule-to-market/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2018/04/05/the-rise-of-smart-cities-understanding-the-future-of-connected-living/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2018/02/05/virtual-measurement-app-aims-to-disrupt-online-apparel-market/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2016/12/15/special-report-cashless-society-contactless-payments/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2016/12/09/kitov-successfully-completes-all-kit-302-testing-required-for-new-drug-application-to-u-s-fda/ 2016-12-09T19:20:44+00:00 0.4096 https://www.corporateprofile.com/2015/12/14/the-changing-face-of-transgender-surgery/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2015/12/09/can-fite-announces-pre-clinical-data-on-cf102-in-the-treatment-of-nash/ 2015-12-10T02:44:04+00:00 0.4096 https://www.corporateprofile.com/2016/02/01/the-most-dangerous-ride-in-nyc-pbr-at-msg/ 2016-02-01T19:56:03+00:00 0.4096 https://www.corporateprofile.com/2015/08/10/interview-with-anne-marie-martinez-a-m-i-lifestyle-creation-agency/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2015/08/06/new-data-show-pluristems-plx-cells-regulate-the-immune-system/ 2015-08-06T20:28:29+00:00 0.4096 https://www.corporateprofile.com/2015/08/20/sneaker-culture-is-on-display-at-the-brooklyn-museum/ 2015-08-20T20:04:36+00:00 0.4096 https://www.corporateprofile.com/2015/07/02/ultra-runner-author-david-clark-talks-running-recovery-the-boston-marathon/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2015/06/22/heat-biologics-announces-development-of-compact-next-gen-combination-immunotherapy-platform/ 2015-06-22T19:34:23+00:00 0.4096 https://www.corporateprofile.com/2015/07/20/cel-sci-expands-its-phase-i-study-with-addition-of-2nd-site-at-ucsf/ 2015-07-20T19:50:06+00:00 0.4096 https://www.corporateprofile.com/2015/05/14/can-fites-phase-ii-liver-cancer-trial-approved-in-europe/ 2015-05-14T21:31:55+00:00 0.4096 https://www.corporateprofile.com/2015/05/14/pluristem-ceo-zami-aberman-psti-entering-japans-accelerated-pathway-for-regenerative-medicine/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2015/06/05/national-donut-day-2015-nyc-w-entenmanns-and-the-salvation-army/ 2015-06-05T19:04:49+00:00 0.4096 https://www.corporateprofile.com/2018/03/05/this-nyc-bakery-can-turn-your-face-into-a-cookie/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2017/12/01/virtual-tour-of-louis-vuittons-volez-voguez-voyagez-nyc-exhibition/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2017/11/17/behind-the-scenes-of-the-macys-thanksgiving-day-parade-2017/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2017/10/13/next-level-nyc-movie-theaters-the-nyc-urban-guidebook/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2017/08/14/us-open-ballperson-making-the-cut/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2017/05/30/print-yourself-in-3d-doob-custom-action-figures/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2017/05/08/laduree-pastry-class-learn-to-make-the-best-selling-ispahan-from-exec-chef-jimmy-leclerc/ 2017-05-08T19:06:07+00:00 0.4096 https://www.corporateprofile.com/2017/02/06/backstage-pass-to-the-rolling-stones-exhibit-w-curator-ileen-gallagher/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2016/11/21/the-past-present-and-future-of-neon-in-new-york-w-let-there-be-neon/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2016/11/02/psti-pivotal-phase-iii-critical-limb-ischemia-trial-approved-by-uk-regulatory-agency/ 2016-11-02T20:50:58+00:00 0.4096 https://www.corporateprofile.com/2016/08/31/nycs-most-instagrammable-foods-the-new-class/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2016/10/19/can-fite-submits-protocol-for-phase-ii-trial-of-cf102-in-the-treatment-of-nafldnash/ 2016-10-19T19:54:43+00:00 0.4096 https://www.corporateprofile.com/2016/07/05/discover-the-nyc-street-art-scene-w-urban-art-expert-gabe-schoenberg-graff-tours/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2016/06/27/oramed-announces-6-5-million-milestone-payment-from-htit/ 2016-06-27T17:58:57+00:00 0.4096 https://www.corporateprofile.com/2016/05/25/the-story-of-janes-carousel-interview-w-jane-walentas/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2016/06/16/can-fite-reports-new-data-on-psoriasis-drug-offering-efficacy-similar-to-industry-leading-biologics/ 2016-06-16T20:53:00+00:00 0.4096 https://www.corporateprofile.com/2016/04/11/eggloos-egg-waffle-ice-cream-cones-are-nycs-newest-dessert-craze/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2016/03/22/make-new-york-style-pizza-at-home-pizza-a-casa-pizza-school/ 2016-03-22T20:52:29+00:00 0.4096 https://www.corporateprofile.com/2015/05/14/labstyle-innovations-receives-health-canada-approval-for-commercialization-of-the-dario/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2015/05/04/oramed-pharmaceuticals-inc-issues-phase-iib-study-update-letter/ 2015-05-04T19:35:14+00:00 0.4096 https://www.corporateprofile.com/2014/11/25/oramed-company-overview-nasdaq-ormp-russian-language-2/feed/ 2026-09-27T04:13:29+00:00 0.4096 https://www.corporateprofile.com/2014/11/12/psti-granted-patents-in-australia-and-new-zealand/ 2014-11-12T22:20:04+00:00 0.4096 https://www.corporateprofile.com/2014/12/02/guinness-world-record-largest-gingerbread-village-gingerbread-lane-at-nysci/ 2014-12-03T01:33:39+00:00 0.4096 https://www.corporateprofile.com/2016/12/09/kitov-successfully-completes-all-kit-302-testing-required-for-new-drug-application-to-u-s-fda/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2016/12/09/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/12/09/can-fite-announces-pre-clinical-data-on-cf102-in-the-treatment-of-nash/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/12/09/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/12/09/oramed-signs-up-to-50-million-licensing-and-investment-agreements-for-oral-insulin-capsule-in-china/ 2015-12-10T02:38:23+00:00 0.3277 https://www.corporateprofile.com/2016/02/01/the-most-dangerous-ride-in-nyc-pbr-at-msg/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2016/02/01/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/08/06/new-data-show-pluristems-plx-cells-regulate-the-immune-system/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/08/06/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/08/06/orgenesis-subsidiary-masthercell-to-manufacture-txcells-lead-product-ovasave/ 2015-08-06T20:23:07+00:00 0.3277 https://www.corporateprofile.com/2015/08/20/sneaker-culture-is-on-display-at-the-brooklyn-museum/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/08/20/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/09/30/rexahn-pharmaceuticals-presents-at-the-european-cancer-congress-2015/ 2015-09-30T19:14:34+00:00 0.3277 https://www.corporateprofile.com/2015/06/22/heat-biologics-announces-development-of-compact-next-gen-combination-immunotherapy-platform/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/06/22/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/06/22/pluristem-awarded-2-9-million-grant-by-israeli-government/ 2015-06-22T19:31:59+00:00 0.3277 https://www.corporateprofile.com/2015/07/20/cel-sci-expands-its-phase-i-study-with-addition-of-2nd-site-at-ucsf/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/07/20/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/07/20/rexahn-pharmaceuticals-awarded-patent-in-japan-for-novel-targeted-cancer-drug-delivery-platform/ 2015-07-20T19:56:53+00:00 0.3277 https://www.corporateprofile.com/2015/05/14/can-fites-phase-ii-liver-cancer-trial-approved-in-europe/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/06/05/national-donut-day-2015-nyc-w-entenmanns-and-the-salvation-army/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/06/05/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/06/09/cel-sci-cleared-for-patient-enrollment-for-its-phase-3-cancer-immunotherapy-trial-in-thailand/ 2015-06-09T18:42:12+00:00 0.3277 https://www.corporateprofile.com/2017/05/08/laduree-pastry-class-learn-to-make-the-best-selling-ispahan-from-exec-chef-jimmy-leclerc/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2017/05/08/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2016/11/02/psti-pivotal-phase-iii-critical-limb-ischemia-trial-approved-by-uk-regulatory-agency/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2016/11/02/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2016/10/19/can-fite-submits-protocol-for-phase-ii-trial-of-cf102-in-the-treatment-of-nafldnash/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2016/10/19/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2016/06/27/oramed-announces-6-5-million-milestone-payment-from-htit/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2016/06/27/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2016/06/27/tapimmune-begins-phase-2-triple-negative-breast-cancer-trial-for-cancer-vaccine-tpiv-200/ 2016-06-27T17:57:12+00:00 0.3277 https://www.corporateprofile.com/2016/06/16/can-fite-reports-new-data-on-psoriasis-drug-offering-efficacy-similar-to-industry-leading-biologics/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2016/06/16/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2016/06/27/psti-data-shows-plx-pad-cells-effective-in-treating-duchenne-muscular-dystrophy/ 2016-06-27T17:52:22+00:00 0.3277 https://www.corporateprofile.com/2016/03/22/make-new-york-style-pizza-at-home-pizza-a-casa-pizza-school/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2016/03/22/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/05/04/oramed-pharmaceuticals-inc-issues-phase-iib-study-update-letter/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/05/04/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2015/05/04/cel-sci-reports-4th-month-of-record-patient-enrollment-for-its-phase-iii-head-and-neck-cancer-trial/ 2015-05-04T18:51:17+00:00 0.3277 https://www.corporateprofile.com/2014/11/12/psti-granted-patents-in-australia-and-new-zealand/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2014/11/12/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2014/11/12/implant-sciences-signs-tsa-idiq-contract-for-up-to-162-million-dollars/ 2014-11-12T20:28:18+00:00 0.3277 https://www.corporateprofile.com/2014/12/02/guinness-world-record-largest-gingerbread-village-gingerbread-lane-at-nysci/feed/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2014/12/02/ 2026-09-27T04:13:29+00:00 0.3277 https://www.corporateprofile.com/2014/12/17/get-on-board-the-ride-nycs-mobile-theater/ 2014-12-17T18:23:00+00:00 0.3277 https://www.corporateprofile.com/2015/12/09/pluristem-signs-mou-with-fukushima-medical-university-to-study-plx-r18-in-acute-radiation-syndrome/ 2015-12-10T02:36:44+00:00 0.2621 https://www.corporateprofile.com/2015/12/09/oramed-signs-up-to-50-million-licensing-and-investment-agreements-for-oral-insulin-capsule-in-china/feed/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2015/08/06/world-health-organization-accepted-piclidenoson-as-new-generic-name-for-can-fites-cf101/ 2015-08-06T20:12:33+00:00 0.2621 https://www.corporateprofile.com/2015/08/06/orgenesis-subsidiary-masthercell-to-manufacture-txcells-lead-product-ovasave/feed/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2015/09/30/rexahn-pharmaceuticals-presents-at-the-european-cancer-congress-2015/feed/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2015/09/30/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2015/09/30/oramed-patent-allowed-in-the-us-for-oral-administration-of-proteins/ 2015-09-30T19:37:34+00:00 0.2621 https://www.corporateprofile.com/2015/06/22/oramed-granted-patent-in-russia-for-oral-administration-of-glp-1/ 2015-06-22T19:28:46+00:00 0.2621 https://www.corporateprofile.com/2015/06/22/pluristem-awarded-2-9-million-grant-by-israeli-government/feed/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2015/07/20/sinopharm-capital-hefei-signs-letter-of-intent-w-ormp-for-50m-investment/ 2015-07-20T20:03:25+00:00 0.2621 https://www.corporateprofile.com/2015/07/20/labstyle-innovations-dario-now-reimbursed-through-a-majority-of-medical-plans-in-canada/ 2015-07-20T20:00:07+00:00 0.2621 https://www.corporateprofile.com/2015/07/20/rexahn-pharmaceuticals-awarded-patent-in-japan-for-novel-targeted-cancer-drug-delivery-platform/feed/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2015/06/09/cel-sci-cleared-for-patient-enrollment-for-its-phase-3-cancer-immunotherapy-trial-in-thailand/feed/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2015/06/09/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2015/06/09/labstyle-innovations-late-breaking-poster-presented-at-american-diabetes-association-75th-scientific-session/ 2015-06-09T19:02:21+00:00 0.2621 https://www.corporateprofile.com/2016/06/27/kitov-reports-kit-302-has-beneficial-effects-on-kidney-function/ 2016-06-27T17:54:36+00:00 0.2621 https://www.corporateprofile.com/2016/06/27/tapimmune-begins-phase-2-triple-negative-breast-cancer-trial-for-cancer-vaccine-tpiv-200/feed/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2016/06/27/psti-data-shows-plx-pad-cells-effective-in-treating-duchenne-muscular-dystrophy/feed/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2015/05/04/labstyle-innovations-launches-online-store-for-dario-blood-glucose-monitoring-system/ 2015-05-04T18:43:26+00:00 0.2621 https://www.corporateprofile.com/2015/05/04/can-fite-reports-positive-results-from-further-analysis-of-phase-iiiii-psoriasis-trial/ 2015-05-04T18:38:40+00:00 0.2621 https://www.corporateprofile.com/2015/05/04/cel-sci-reports-4th-month-of-record-patient-enrollment-for-its-phase-iii-head-and-neck-cancer-trial/feed/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2014/11/12/implant-sciences-signs-tsa-idiq-contract-for-up-to-162-million-dollars/feed/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2014/11/10/interview-with-rightscorp-ceo-christopher-sabec/ 2014-11-25T20:49:10+00:00 0.2621 https://www.corporateprofile.com/2014/12/17/get-on-board-the-ride-nycs-mobile-theater/feed/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2014/12/17/ 2026-09-27T04:13:29+00:00 0.2621 https://www.corporateprofile.com/2014/12/18/pluristem-granted-patent-in-singapore-for-its-3d-cell-expansion-technology/ 2014-12-18T18:24:41+00:00 0.2621 https://www.corporateprofile.com/2015/12/09/pluristem-signs-mou-with-fukushima-medical-university-to-study-plx-r18-in-acute-radiation-syndrome/feed/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2015/11/16/relive-40-years-of-snl-at-saturday-night-live-the-exhibition/ 2015-11-16T19:02:50+00:00 0.2097 https://www.corporateprofile.com/2015/08/06/world-health-organization-accepted-piclidenoson-as-new-generic-name-for-can-fites-cf101/feed/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2015/09/30/u-s-fda-grants-fast-track-designation-to-can-fites-cf102/ 2015-09-30T19:43:07+00:00 0.2097 https://www.corporateprofile.com/2015/09/30/pluristem-and-niaid-met-with-u-s-fda-and-agreed-on-development-plan/ 2015-09-30T19:39:55+00:00 0.2097 https://www.corporateprofile.com/2015/09/30/oramed-patent-allowed-in-the-us-for-oral-administration-of-proteins/feed/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2015/06/22/oramed-granted-patent-in-russia-for-oral-administration-of-glp-1/feed/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2015/06/09/national-cancer-institute-accepts-rexahns-rx-21101-for-its-nanotechnology-characterization-laboratorys-preclinical-characterization-program/ 2015-06-09T19:21:11+00:00 0.2097 https://www.corporateprofile.com/2015/07/20/sinopharm-capital-hefei-signs-letter-of-intent-w-ormp-for-50m-investment/feed/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2015/07/20/labstyle-innovations-dario-now-reimbursed-through-a-majority-of-medical-plans-in-canada/feed/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2015/06/09/labstyle-innovations-late-breaking-poster-presented-at-american-diabetes-association-75th-scientific-session/feed/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2016/06/27/kitov-reports-kit-302-has-beneficial-effects-on-kidney-function/feed/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2015/05/04/labstyle-innovations-launches-online-store-for-dario-blood-glucose-monitoring-system/feed/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2015/05/04/can-fite-reports-positive-results-from-further-analysis-of-phase-iiiii-psoriasis-trial/feed/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2015/04/28/company-overview-w-labstyle-innovations-ceo-erez-raphael-drio/ 2015-04-28T19:08:11+00:00 0.2097 https://www.corporateprofile.com/2014/11/10/interview-with-rightscorp-ceo-christopher-sabec/feed/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2014/11/10/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2014/10/07/canf-ceo-dr-fishman-to-co-chair-and-present-at-19th-world-congress-on-advances-in-cancer-therapy/ 2014-10-07T23:06:46+00:00 0.2097 https://www.corporateprofile.com/2014/12/18/pluristem-granted-patent-in-singapore-for-its-3d-cell-expansion-technology/feed/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2014/12/18/ 2026-09-27T04:13:29+00:00 0.2097 https://www.corporateprofile.com/2014/12/18/pluristem-and-hadassah-medical-center-collaborate-to-study-plx-rad-cells/ 2014-12-18T19:23:17+00:00 0.2097 https://www.corporateprofile.com/2015/11/16/relive-40-years-of-snl-at-saturday-night-live-the-exhibition/feed/ 2026-09-27T04:13:29+00:00 0.1678 https://www.corporateprofile.com/2015/11/16/ 2026-09-27T04:13:29+00:00 0.1678 https://www.corporateprofile.com/2015/11/13/cel-scis-rheumatoid-arthritis-vaccine-selected-for-commercialization-program-niche-analysis-plan/ 2015-11-13T17:33:13+00:00 0.1678 https://www.corporateprofile.com/2015/09/30/u-s-fda-grants-fast-track-designation-to-can-fites-cf102/feed/ 2026-09-27T04:13:29+00:00 0.1678 https://www.corporateprofile.com/2015/11/13/dario-diabetes-management-solution-to-launch-in-india/ 2015-11-13T17:08:15+00:00 0.1678 https://www.corporateprofile.com/2015/09/30/pluristem-and-niaid-met-with-u-s-fda-and-agreed-on-development-plan/feed/ 2026-09-27T04:13:29+00:00 0.1678 https://www.corporateprofile.com/2015/06/09/national-cancer-institute-accepts-rexahns-rx-21101-for-its-nanotechnology-characterization-laboratorys-preclinical-characterization-program/feed/ 2026-09-27T04:13:29+00:00 0.1678 https://www.corporateprofile.com/2015/04/28/company-overview-w-labstyle-innovations-ceo-erez-raphael-drio/feed/ 2026-09-27T04:13:29+00:00 0.1678 https://www.corporateprofile.com/2015/04/28/ 2026-09-27T04:13:29+00:00 0.1678 https://www.corporateprofile.com/2015/04/23/pluristem-prepares-for-phase-ii-clinical-trials-in-critical-limb-ischemia-in-europe-and-japan/ 2015-04-23T21:38:56+00:00 0.1678 https://www.corporateprofile.com/2014/10/07/canf-ceo-dr-fishman-to-co-chair-and-present-at-19th-world-congress-on-advances-in-cancer-therapy/feed/ 2026-09-27T04:13:29+00:00 0.1678 https://www.corporateprofile.com/2014/10/07/ 2026-09-27T04:13:29+00:00 0.1678 https://www.corporateprofile.com/2014/10/06/implant-sciences-qs-b220-passes-european-civil-aviation-conference-common-evaluation-process/ 2014-10-06T23:04:08+00:00 0.1678 https://www.corporateprofile.com/2014/12/18/cel-sci-expands-its-pivotal-phase-iii-immunotherapy-trial-with-addition-of-7-more-clinical-sites/ 2014-12-18T21:36:38+00:00 0.1678 https://www.corporateprofile.com/2014/12/18/pluristem-and-hadassah-medical-center-collaborate-to-study-plx-rad-cells/feed/ 2026-09-27T04:13:29+00:00 0.1678 https://www.corporateprofile.com/2015/11/13/cel-scis-rheumatoid-arthritis-vaccine-selected-for-commercialization-program-niche-analysis-plan/feed/ 2026-09-27T04:13:29+00:00 0.1342 https://www.corporateprofile.com/2015/11/13/ 2026-09-27T04:13:29+00:00 0.1342 https://www.corporateprofile.com/2015/11/13/rexahn-reports-clinical-data-for-archexin/ 2015-11-13T17:30:54+00:00 0.1342 https://www.corporateprofile.com/2015/11/13/dario-diabetes-management-solution-to-launch-in-india/feed/ 2026-09-27T04:13:29+00:00 0.1342 https://www.corporateprofile.com/2015/04/23/pluristem-prepares-for-phase-ii-clinical-trials-in-critical-limb-ischemia-in-europe-and-japan/feed/ 2026-09-27T04:13:29+00:00 0.1342 https://www.corporateprofile.com/2015/04/23/ 2026-09-27T04:13:29+00:00 0.1342 https://www.corporateprofile.com/2015/04/23/rexahns-supinoxin-decreases-migration-of-breast-cancer-cells-in-metastatic-cancer-model/ 2015-04-23T21:27:34+00:00 0.1342 https://www.corporateprofile.com/2014/10/06/implant-sciences-qs-b220-passes-european-civil-aviation-conference-common-evaluation-process/feed/ 2026-09-27T04:13:29+00:00 0.1342 https://www.corporateprofile.com/2014/10/06/ 2026-09-27T04:13:29+00:00 0.1342 https://www.corporateprofile.com/2014/10/06/pluristem-corporate-profile-interview-with-dr-karine-kleinhaus/ 2015-03-14T23:01:56+00:00 0.1342 https://www.corporateprofile.com/2014/12/18/cel-sci-expands-its-pivotal-phase-iii-immunotherapy-trial-with-addition-of-7-more-clinical-sites/feed/ 2026-09-27T04:13:29+00:00 0.1342 https://www.corporateprofile.com/2015/01/06/pluristem-granted-patent-for-foundational-cell-harvesting-technology-in-south-africa/ 2015-01-06T19:13:05+00:00 0.1342 https://www.corporateprofile.com/2015/11/13/rexahn-reports-clinical-data-for-archexin/feed/ 2026-09-27T04:13:29+00:00 0.1074 https://www.corporateprofile.com/2015/04/23/can-fite-applies-for-orphan-drug-designation-in-europe-for-cf102-in-the-treatment-of-liver-cancer/ 2015-04-23T21:24:40+00:00 0.1074 https://www.corporateprofile.com/2015/04/23/uks-aintree-university-hospital-joins-cel-scis-phase-iii-head-and-neck-cancer-trial/ 2015-04-23T19:24:15+00:00 0.1074 https://www.corporateprofile.com/2015/04/23/rexahns-supinoxin-decreases-migration-of-breast-cancer-cells-in-metastatic-cancer-model/feed/ 2026-09-27T04:13:29+00:00 0.1074 https://www.corporateprofile.com/2014/10/06/pluristem-corporate-profile-interview-with-dr-karine-kleinhaus/feed/ 2026-09-27T04:13:29+00:00 0.1074 https://www.corporateprofile.com/2014/10/03/pluristem-company-overview-russian-language/ 2014-10-03T19:46:09+00:00 0.1074 https://www.corporateprofile.com/2015/01/06/pluristem-granted-patent-for-foundational-cell-harvesting-technology-in-south-africa/feed/ 2026-09-27T04:13:29+00:00 0.1074 https://www.corporateprofile.com/2015/01/06/ 2026-09-27T04:13:29+00:00 0.1074 https://www.corporateprofile.com/2015/01/06/cel-scis-2014-patient-enrollment-increases-eight-fold-over-2013/ 2015-01-06T20:48:29+00:00 0.1074 https://www.corporateprofile.com/2015/04/23/can-fite-applies-for-orphan-drug-designation-in-europe-for-cf102-in-the-treatment-of-liver-cancer/feed/ 2026-09-27T04:13:29+00:00 0.0859 https://www.corporateprofile.com/2015/04/23/uks-aintree-university-hospital-joins-cel-scis-phase-iii-head-and-neck-cancer-trial/feed/ 2026-09-27T04:13:29+00:00 0.0859 https://www.corporateprofile.com/2015/04/20/the-worlds-first-internet-connected-smart-doll-my-friend-cayla-tfny15/ 2015-04-20T19:01:52+00:00 0.0859 https://www.corporateprofile.com/2014/10/03/pluristem-company-overview-russian-language/feed/ 2026-09-27T04:13:29+00:00 0.0859 https://www.corporateprofile.com/2014/10/03/ 2026-09-27T04:13:29+00:00 0.0859 https://www.corporateprofile.com/2014/10/01/cel-sci-u-s-navy-administer-multikine-to-first-volunteer-patient-in-phase-i-clinical-trial/ 2014-10-01T18:10:09+00:00 0.0859 https://www.corporateprofile.com/2015/01/06/rnn-preclinical-data-for-rx-3117-effectiveness-against-resistant-cancer-cells/ 2015-01-06T22:11:19+00:00 0.0859 https://www.corporateprofile.com/2015/01/06/can-fite-announces-upcoming-2015-clinical-milestones-for-its-pipeline-of-drugs-in-4-indications/ 2015-01-06T20:38:19+00:00 0.0859 https://www.corporateprofile.com/2015/01/06/cel-scis-2014-patient-enrollment-increases-eight-fold-over-2013/feed/ 2026-09-27T04:13:29+00:00 0.0859 https://www.corporateprofile.com/2015/04/20/the-worlds-first-internet-connected-smart-doll-my-friend-cayla-tfny15/feed/ 2026-09-27T04:13:29+00:00 0.0687 https://www.corporateprofile.com/2015/04/20/ 2026-09-27T04:13:29+00:00 0.0687 https://www.corporateprofile.com/2015/04/13/see-whats-new-from-lalaloopsy-meet-vi-and-va-mga-entertainment-tfny-15/ 2015-04-13T19:58:05+00:00 0.0687 https://www.corporateprofile.com/2014/10/01/cel-sci-u-s-navy-administer-multikine-to-first-volunteer-patient-in-phase-i-clinical-trial/feed/ 2026-09-27T04:13:29+00:00 0.0687 https://www.corporateprofile.com/2014/10/01/ 2026-09-27T04:13:29+00:00 0.0687 https://www.corporateprofile.com/2014/10/01/u-s-patent-and-trademark-office-issues-can-fite-patent-for-cf102/ 2014-10-01T16:06:21+00:00 0.0687 https://www.corporateprofile.com/2015/01/06/rnn-preclinical-data-for-rx-3117-effectiveness-against-resistant-cancer-cells/feed/ 2026-09-27T04:13:29+00:00 0.0687 https://www.corporateprofile.com/2015/01/22/implant-sciences-explosives-and-drug-trace-detectors-approved-for-use-in-russia/ 2015-01-22T19:20:44+00:00 0.0687 https://www.corporateprofile.com/2015/01/06/can-fite-announces-upcoming-2015-clinical-milestones-for-its-pipeline-of-drugs-in-4-indications/feed/ 2026-09-27T04:13:29+00:00 0.0687 https://www.corporateprofile.com/2015/04/13/see-whats-new-from-lalaloopsy-meet-vi-and-va-mga-entertainment-tfny-15/feed/ 2026-09-27T04:13:29+00:00 0.0550 https://www.corporateprofile.com/2015/04/13/ 2026-09-27T04:13:29+00:00 0.0550 https://www.corporateprofile.com/2015/04/07/cel-sci-reports-3rd-month-of-record-patient-enrollment-in-2015-for-its-phase-iii-cancer-trial/ 2015-04-07T17:25:14+00:00 0.0550 https://www.corporateprofile.com/2014/10/01/u-s-patent-and-trademark-office-issues-can-fite-patent-for-cf102/feed/ 2026-09-27T04:13:29+00:00 0.0550 https://www.corporateprofile.com/2014/09/26/rexahn-receives-fda-orphan-drug-designation-for-rx-3117-in-treatment-of-pancreatic-cancer/ 2014-09-26T19:32:01+00:00 0.0550 https://www.corporateprofile.com/2015/01/22/implant-sciences-explosives-and-drug-trace-detectors-approved-for-use-in-russia/feed/ 2026-09-27T04:13:29+00:00 0.0550 https://www.corporateprofile.com/2015/01/22/ 2026-09-27T04:13:29+00:00 0.0550 https://www.corporateprofile.com/2015/01/22/oramed-granted-patent-in-israel-for-oral-administration-of-glp-1/ 2015-01-22T20:45:03+00:00 0.0550 https://www.corporateprofile.com/2015/04/07/cel-sci-reports-3rd-month-of-record-patient-enrollment-in-2015-for-its-phase-iii-cancer-trial/feed/ 2026-09-27T04:13:29+00:00 0.0440 https://www.corporateprofile.com/2015/04/07/ 2026-09-27T04:13:29+00:00 0.0440 https://www.corporateprofile.com/2015/04/07/major-international-airline-in-latin-america-adopts-qs-b220/ 2015-04-07T16:45:08+00:00 0.0440 https://www.corporateprofile.com/2014/09/26/rexahn-receives-fda-orphan-drug-designation-for-rx-3117-in-treatment-of-pancreatic-cancer/feed/ 2026-09-27T04:13:29+00:00 0.0440 https://www.corporateprofile.com/2014/09/26/ 2026-09-27T04:13:29+00:00 0.0440 https://www.corporateprofile.com/2014/09/23/interview-with-borneo-resource-invest-ceo-nils-ollquist/ 2014-09-23T21:55:09+00:00 0.0440 https://www.corporateprofile.com/2015/01/22/oramed-granted-patent-in-israel-for-oral-administration-of-glp-1/feed/ 2026-09-27T04:13:29+00:00 0.0440 https://www.corporateprofile.com/2015/01/30/can-fites-cf602-demonstrates-efficacy-in-treatment-of-sexual-dysfunction-in-preclinical-studies-2/ 2015-01-30T20:53:47+00:00 0.0440 https://www.corporateprofile.com/2015/04/07/oramed-enrolls-first-patient-in-its-glucose-clamp-study-for-oral-insulin/ 2015-04-07T16:09:30+00:00 0.0352 https://www.corporateprofile.com/2015/04/07/major-international-airline-in-latin-america-adopts-qs-b220/feed/ 2026-09-27T04:13:29+00:00 0.0352 https://www.corporateprofile.com/2014/09/23/interview-with-borneo-resource-invest-ceo-nils-ollquist/feed/ 2026-09-27T04:13:29+00:00 0.0352 https://www.corporateprofile.com/2014/09/23/ 2026-09-27T04:13:29+00:00 0.0352 https://www.corporateprofile.com/2014/09/18/itus-announces-patent-infringement-lawsuit-against-apple/ 2014-09-18T21:36:21+00:00 0.0352 https://www.corporateprofile.com/2015/01/30/can-fites-cf602-demonstrates-efficacy-in-treatment-of-sexual-dysfunction-in-preclinical-studies-2/feed/ 2026-09-27T04:13:29+00:00 0.0352 https://www.corporateprofile.com/2015/01/30/ 2026-09-27T04:13:29+00:00 0.0352 https://www.corporateprofile.com/2015/01/30/htbx-presents-positive-immunological-data-on-hs-410-at-phacilitate-immunotherapy-forum-2015-3/ 2015-01-30T21:50:33+00:00 0.0352 https://www.corporateprofile.com/2015/04/07/oramed-enrolls-first-patient-in-its-glucose-clamp-study-for-oral-insulin/feed/ 2026-09-27T04:13:29+00:00 0.0281 https://www.corporateprofile.com/2015/04/06/interview-with-heat-biologics-ceo-jeffrey-wolf-on-the-companys-impact-therapy/ 2015-04-07T01:15:15+00:00 0.0281 https://www.corporateprofile.com/2014/09/18/itus-announces-patent-infringement-lawsuit-against-apple/feed/ 2026-09-27T04:13:29+00:00 0.0281 https://www.corporateprofile.com/2014/09/18/ 2026-09-27T04:13:29+00:00 0.0281 https://www.corporateprofile.com/2014/09/18/pluristem-pursues-development-strategy-in-japan-where-new-law-accelerates-path-to-market/ 2014-09-18T20:46:49+00:00 0.0281 https://www.corporateprofile.com/2015/01/30/the-cannabiz-report-the-business-of-cannabis-managing-editor-richard-friedman/ 2015-03-14T23:03:37+00:00 0.0281 https://www.corporateprofile.com/2015/01/30/htbx-presents-positive-immunological-data-on-hs-410-at-phacilitate-immunotherapy-forum-2015-3/feed/ 2026-09-27T04:13:29+00:00 0.0281 https://www.corporateprofile.com/2015/04/06/interview-with-heat-biologics-ceo-jeffrey-wolf-on-the-companys-impact-therapy/feed/ 2026-09-27T04:13:29+00:00 0.0225 https://www.corporateprofile.com/2015/04/06/ 2026-09-27T04:13:29+00:00 0.0225 https://www.corporateprofile.com/2015/04/03/unleash-the-force-w-the-force-trainer-ii-star-wars-science-from-uncle-milton-tfny-15/ 2015-04-03T18:27:08+00:00 0.0225 https://www.corporateprofile.com/2014/09/18/can-fites-drug-cf101-is-presented-in-scientific-journal-for-the-treatment-of-psoriasis/ 2014-09-18T19:22:17+00:00 0.0225 https://www.corporateprofile.com/2014/09/18/itus-subsidiary-enters-into-settlement-agreement-with-jeld-wen/ 2014-09-18T18:12:38+00:00 0.0225 https://www.corporateprofile.com/2014/09/18/pluristem-pursues-development-strategy-in-japan-where-new-law-accelerates-path-to-market/feed/ 2026-09-27T04:13:29+00:00 0.0225 https://www.corporateprofile.com/2015/01/30/the-cannabiz-report-the-business-of-cannabis-managing-editor-richard-friedman/feed/ 2026-09-27T04:13:29+00:00 0.0225 https://www.corporateprofile.com/2015/02/02/pluristem-new-finding-from-phase-iii-muscle-injury-trial/ 2015-02-02T23:29:49+00:00 0.0225 https://www.corporateprofile.com/2015/04/03/unleash-the-force-w-the-force-trainer-ii-star-wars-science-from-uncle-milton-tfny-15/feed/ 2026-09-27T04:13:29+00:00 0.0180 https://www.corporateprofile.com/2015/04/03/ 2026-09-27T04:13:29+00:00 0.0180 https://www.corporateprofile.com/2015/03/30/preview-of-legos-largest-product-rollout-ever-toy-fair-2015/ 2015-03-30T19:06:39+00:00 0.0180 https://www.corporateprofile.com/2014/09/18/can-fites-drug-cf101-is-presented-in-scientific-journal-for-the-treatment-of-psoriasis/feed/ 2026-09-27T04:13:29+00:00 0.0180 https://www.corporateprofile.com/2014/09/18/itus-subsidiary-enters-into-settlement-agreement-with-jeld-wen/feed/ 2026-09-27T04:13:29+00:00 0.0180 https://www.corporateprofile.com/2014/09/12/bluesphere-signs-memorandum-of-understanding-with-esc-an-israeli-state-owned-company-for-a-5-mw-biogas-project-in-israel/ 2014-09-12T22:02:34+00:00 0.0180 https://www.corporateprofile.com/2015/02/02/pluristem-new-finding-from-phase-iii-muscle-injury-trial/feed/ 2026-09-27T04:13:29+00:00 0.0180 https://www.corporateprofile.com/2015/02/02/ 2026-09-27T04:13:29+00:00 0.0180 https://www.corporateprofile.com/2015/02/02/interview-with-bioshares-founder-paul-yook/ 2015-02-02T23:31:49+00:00 0.0180 https://www.corporateprofile.com/2015/03/30/preview-of-legos-largest-product-rollout-ever-toy-fair-2015/feed/ 2026-09-27T04:13:29+00:00 0.0144 https://www.corporateprofile.com/2015/03/30/ 2026-09-27T04:13:29+00:00 0.0144 https://www.corporateprofile.com/2015/03/25/sky-viper-drones-in-flight-chocolate-pen-delight-skyrocket-toys-tfny-15/ 2015-03-25T20:27:05+00:00 0.0144 https://www.corporateprofile.com/2014/09/12/bluesphere-signs-memorandum-of-understanding-with-esc-an-israeli-state-owned-company-for-a-5-mw-biogas-project-in-israel/feed/ 2026-09-27T04:13:29+00:00 0.0144 https://www.corporateprofile.com/2014/09/12/ 2026-09-27T04:13:29+00:00 0.0144 https://www.corporateprofile.com/2014/09/12/itus-subsidiary-settles-patent-infringement-lawsuits-with-atrium-windows-pella-ply-gem-and-simonton/ 2014-09-12T21:38:47+00:00 0.0144 https://www.corporateprofile.com/2015/02/02/interview-with-bioshares-founder-paul-yook/feed/ 2026-09-27T04:13:29+00:00 0.0144 https://www.corporateprofile.com/2015/02/19/toy-fair-new-york-2015-highlights/ 2015-02-19T18:36:35+00:00 0.0144 https://www.corporateprofile.com/2015/03/25/sky-viper-drones-in-flight-chocolate-pen-delight-skyrocket-toys-tfny-15/feed/ 2026-09-27T04:13:29+00:00 0.0115 https://www.corporateprofile.com/2015/03/25/ 2026-09-27T04:13:29+00:00 0.0115 https://www.corporateprofile.com/2015/03/22/carve-wrap-color-alive-with-crayola-at-toy-fair-2015/ 2015-03-22T17:12:52+00:00 0.0115 https://www.corporateprofile.com/2014/09/12/university-of-minnesota-masonic-cancer-center-joins-cel-scis-phase-iii-head-neck-cancer-trial/ 2014-09-12T21:11:55+00:00 0.0115 https://www.corporateprofile.com/2014/09/12/united-therapeutics-advances-to-second-cohort-in-phase-i-trial-of-pstis-plx-pad-cells/ 2014-09-12T20:34:27+00:00 0.0115 https://www.corporateprofile.com/2014/09/12/implant-sciences-sells-12-qs-b220-explosives-trace-detectors-to-south-koreas-largest-airport/ 2014-09-12T19:12:43+00:00 0.0115 https://www.corporateprofile.com/2014/09/12/itus-subsidiary-settles-patent-infringement-lawsuits-with-atrium-windows-pella-ply-gem-and-simonton/feed/ 2026-09-27T04:13:29+00:00 0.0115 https://www.corporateprofile.com/2015/02/19/toy-fair-new-york-2015-highlights/feed/ 2026-09-27T04:13:29+00:00 0.0115 https://www.corporateprofile.com/2015/02/19/ 2026-09-27T04:13:29+00:00 0.0115 https://www.corporateprofile.com/2015/02/19/get-crazy-with-razor-at-the-ny-toy-fair-2015/ 2015-02-20T01:48:32+00:00 0.0115 https://www.corporateprofile.com/2015/03/22/carve-wrap-color-alive-with-crayola-at-toy-fair-2015/feed/ 2026-09-27T04:13:29+00:00 0.0092 https://www.corporateprofile.com/2015/03/22/ 2026-09-27T04:13:29+00:00 0.0092 https://www.corporateprofile.com/2015/03/19/can-fite-completes-development-of-commercial-biomarker-test/ 2015-03-19T22:18:34+00:00 0.0092 https://www.corporateprofile.com/2014/09/12/university-of-minnesota-masonic-cancer-center-joins-cel-scis-phase-iii-head-neck-cancer-trial/feed/ 2026-09-27T04:13:29+00:00 0.0092 https://www.corporateprofile.com/2014/09/12/united-therapeutics-advances-to-second-cohort-in-phase-i-trial-of-pstis-plx-pad-cells/feed/ 2026-09-27T04:13:29+00:00 0.0092 https://www.corporateprofile.com/2014/09/12/implant-sciences-sells-12-qs-b220-explosives-trace-detectors-to-south-koreas-largest-airport/feed/ 2026-09-27T04:13:29+00:00 0.0092 https://www.corporateprofile.com/2014/09/05/can-fite-issued-japanese-patent-for-treatment-of-liver-regeneration/ 2014-09-05T18:13:05+00:00 0.0092 https://www.corporateprofile.com/2015/02/19/get-crazy-with-razor-at-the-ny-toy-fair-2015/feed/ 2026-09-27T04:13:29+00:00 0.0092 https://www.corporateprofile.com/2015/02/20/can-fite-completes-phase-iiiii-trial-for-cf101-in-treatment-of-psoriasis/ 2015-02-20T19:21:38+00:00 0.0092 https://www.corporateprofile.com/2015/03/19/can-fite-completes-development-of-commercial-biomarker-test/feed/ 2026-09-27T04:13:29+00:00 0.0074 https://www.corporateprofile.com/2015/03/19/ 2026-09-27T04:13:29+00:00 0.0074 https://www.corporateprofile.com/2015/03/19/labstyle-innovations-successful-user-performance-evaluation-study-to-support-510k-application/ 2015-03-19T20:34:04+00:00 0.0074 https://www.corporateprofile.com/2014/09/05/can-fite-issued-japanese-patent-for-treatment-of-liver-regeneration/feed/ 2026-09-27T04:13:29+00:00 0.0074 https://www.corporateprofile.com/2014/09/05/ 2026-09-27T04:13:29+00:00 0.0074 https://www.corporateprofile.com/2014/09/04/implant-sciences-qs-b220-approved-for-passenger-and-baggage-screening-at-u-s-airports/ 2014-09-04T20:32:43+00:00 0.0074 https://www.corporateprofile.com/2015/02/20/can-fite-completes-phase-iiiii-trial-for-cf101-in-treatment-of-psoriasis/feed/ 2026-09-27T04:13:29+00:00 0.0074 https://www.corporateprofile.com/2015/02/20/ 2026-09-27T04:13:29+00:00 0.0074 https://www.corporateprofile.com/2015/02/20/heat-biologics-inc-and-oncosec-medical-inc-announce-collaboration/ 2015-02-20T19:21:19+00:00 0.0074 https://www.corporateprofile.com/2015/03/19/htbx-receives-us-fda-fast-track-designation-for-hs-410/ 2015-03-19T19:39:34+00:00 0.0059 https://www.corporateprofile.com/2015/03/19/interview-w-crowdgather-ceo-sanjay-sabnani-about-the-future-of-crwg-social-gaming/ 2015-03-19T19:00:45+00:00 0.0059 https://www.corporateprofile.com/2015/03/19/labstyle-innovations-successful-user-performance-evaluation-study-to-support-510k-application/feed/ 2026-09-27T04:13:29+00:00 0.0059 https://www.corporateprofile.com/2014/09/04/implant-sciences-qs-b220-approved-for-passenger-and-baggage-screening-at-u-s-airports/feed/ 2026-09-27T04:13:29+00:00 0.0059 https://www.corporateprofile.com/2014/09/04/ 2026-09-27T04:13:29+00:00 0.0059 https://www.corporateprofile.com/2014/09/04/dskx-to-open-its-first-hair-loss-clinic-for-personalized-therapies-for-hair-loss/ 2014-09-04T19:36:53+00:00 0.0059 https://www.corporateprofile.com/2015/02/20/significant-findings-in-u-s-national-institutes-of-healths-trial-of-pluristems-plx-r18-cells/ 2015-02-20T19:20:26+00:00 0.0059 https://www.corporateprofile.com/2015/02/20/cel-sci-cleared-to-begin-patient-enrollment-in-malaysia/ 2015-02-20T19:20:57+00:00 0.0059 https://www.corporateprofile.com/2015/02/20/heat-biologics-inc-and-oncosec-medical-inc-announce-collaboration/feed/ 2026-09-27T04:13:29+00:00 0.0059 https://www.corporateprofile.com/2015/03/19/htbx-receives-us-fda-fast-track-designation-for-hs-410/feed/ 2026-09-27T04:13:29+00:00 0.0047 https://www.corporateprofile.com/2015/03/19/interview-w-crowdgather-ceo-sanjay-sabnani-about-the-future-of-crwg-social-gaming/feed/ 2026-09-27T04:13:29+00:00 0.0047 https://www.corporateprofile.com/2015/03/17/build-blasters-coasters-big-ideas-with-knex-at-toy-fair-15/ 2015-03-17T18:00:58+00:00 0.0047 https://www.corporateprofile.com/2014/09/04/implant-sciences-wins-1-2-million-contract-for-trace-detectors-to-eu-country/ 2014-09-04T19:09:13+00:00 0.0047 https://www.corporateprofile.com/2014/09/04/rnn-receives-allowance-from-u-s-patent-and-trademark-office-for-cancer-drug-delivery-platform/ 2014-09-04T18:40:03+00:00 0.0047 https://www.corporateprofile.com/2014/09/04/cel-sci-enrolls-20-patients-in-august-in-its-phase-iii-immunotherapy-head-and-neck-cancer-trial/ 2014-09-04T18:09:43+00:00 0.0047 https://www.corporateprofile.com/2014/09/04/dskx-to-open-its-first-hair-loss-clinic-for-personalized-therapies-for-hair-loss/feed/ 2026-09-27T04:13:29+00:00 0.0047 https://www.corporateprofile.com/2015/02/20/significant-findings-in-u-s-national-institutes-of-healths-trial-of-pluristems-plx-r18-cells/feed/ 2026-09-27T04:13:29+00:00 0.0047 https://www.corporateprofile.com/2015/02/24/madame-alexanders-new-look-dolls-unveiled-at-toy-fair-ny-15/ 2015-02-25T00:54:59+00:00 0.0047 https://www.corporateprofile.com/2015/02/20/cel-sci-cleared-to-begin-patient-enrollment-in-malaysia/feed/ 2026-09-27T04:13:29+00:00 0.0047 https://www.corporateprofile.com/2015/03/17/build-blasters-coasters-big-ideas-with-knex-at-toy-fair-15/feed/ 2026-09-27T04:13:29+00:00 0.0038 https://www.corporateprofile.com/2015/03/17/ 2026-09-27T04:13:29+00:00 0.0038 https://www.corporateprofile.com/2015/03/11/meet-meccanoid-g15-ks-your-new-robot-friend-at-toy-fair-ny-15/ 2015-03-11T19:48:58+00:00 0.0038 https://www.corporateprofile.com/2014/09/04/implant-sciences-wins-1-2-million-contract-for-trace-detectors-to-eu-country/feed/ 2026-09-27T04:13:29+00:00 0.0038 https://www.corporateprofile.com/2014/09/04/rnn-receives-allowance-from-u-s-patent-and-trademark-office-for-cancer-drug-delivery-platform/feed/ 2026-09-27T04:13:29+00:00 0.0038 https://www.corporateprofile.com/2014/09/04/cel-sci-enrolls-20-patients-in-august-in-its-phase-iii-immunotherapy-head-and-neck-cancer-trial/feed/ 2026-09-27T04:13:29+00:00 0.0038 https://www.corporateprofile.com/2014/08/22/bluesphere-ceos-article-on-commercial-food-waste-ban-published-in-renewablebiz-magazine/ 2014-08-22T21:50:27+00:00 0.0038 https://www.corporateprofile.com/2015/02/24/madame-alexanders-new-look-dolls-unveiled-at-toy-fair-ny-15/feed/ 2026-09-27T04:13:29+00:00 0.0038 https://www.corporateprofile.com/2015/02/24/ 2026-09-27T04:13:29+00:00 0.0038 https://www.corporateprofile.com/2015/03/02/the-future-of-ai-tech-toys-wowwees-miposaur-r-e-v-at-toy-fair-ny-15/ 2015-03-02T21:47:48+00:00 0.0038 https://www.corporateprofile.com/2015/03/11/meet-meccanoid-g15-ks-your-new-robot-friend-at-toy-fair-ny-15/feed/ 2026-09-27T04:13:29+00:00 0.0030 https://www.corporateprofile.com/2015/03/11/ 2026-09-27T04:13:29+00:00 0.0030 https://www.corporateprofile.com/2015/03/09/take-a-ride-into-the-future-of-lionel-trains-at-tfny-celebrating-115-years/ 2015-03-09T17:44:51+00:00 0.0030 https://www.corporateprofile.com/2014/08/22/bluesphere-ceos-article-on-commercial-food-waste-ban-published-in-renewablebiz-magazine/feed/ 2026-09-27T04:13:29+00:00 0.0030 https://www.corporateprofile.com/2014/08/22/ 2026-09-27T04:13:29+00:00 0.0030 https://www.corporateprofile.com/2014/08/22/biogas-opportunities-road-map-report-from-u-s-government-points-to-huge-opportunity-for-bluesphere/ 2014-08-22T20:16:26+00:00 0.0030 https://www.corporateprofile.com/2015/03/02/the-future-of-ai-tech-toys-wowwees-miposaur-r-e-v-at-toy-fair-ny-15/feed/ 2026-09-27T04:13:29+00:00 0.0030 https://www.corporateprofile.com/2015/03/02/ 2026-09-27T04:13:29+00:00 0.0030 https://www.corporateprofile.com/2015/03/02/bake-girl-scout-cookies-at-home-w-wicked-cool-toys-gs-cookie-oven-ny-toy-fair-15/ 2015-03-02T21:50:10+00:00 0.0030 https://www.corporateprofile.com/2015/03/09/take-a-ride-into-the-future-of-lionel-trains-at-tfny-celebrating-115-years/feed/ 2026-09-27T04:13:29+00:00 0.0024 https://www.corporateprofile.com/2015/03/09/ 2026-09-27T04:13:29+00:00 0.0024 https://www.corporateprofile.com/2015/03/08/fire-away-day-or-night-w-the-led-firetek-bow-rocket-from-zing-toys-toy-fair-ny-15/ 2015-03-09T01:40:38+00:00 0.0024 https://www.corporateprofile.com/2014/08/22/oramed-granted-patent-in-spain-for-oral-administration-of-insulin/ 2014-08-22T19:03:25+00:00 0.0024 https://www.corporateprofile.com/2014/08/22/ds-healthcare-group-reports-second-quarter-2014-financial-results/ 2014-08-22T18:36:51+00:00 0.0024 https://www.corporateprofile.com/2014/08/22/cel-sci-expands-its-global-phase-iii-trial-into-centre-hospitalier-universitaire-de-quebec-in-canada/ 2014-08-22T18:18:14+00:00 0.0024 https://www.corporateprofile.com/2014/08/22/biogas-opportunities-road-map-report-from-u-s-government-points-to-huge-opportunity-for-bluesphere/feed/ 2026-09-27T04:13:29+00:00 0.0024 https://www.corporateprofile.com/2015/03/02/bake-girl-scout-cookies-at-home-w-wicked-cool-toys-gs-cookie-oven-ny-toy-fair-15/feed/ 2026-09-27T04:13:29+00:00 0.0024 https://www.corporateprofile.com/2015/03/04/wafergen-announces-positive-results-of-a-single-cell-study-utilizing-its-smartchip-technology/ 2015-03-04T17:29:21+00:00 0.0024 https://www.corporateprofile.com/2015/03/08/fire-away-day-or-night-w-the-led-firetek-bow-rocket-from-zing-toys-toy-fair-ny-15/feed/ 2026-09-27T04:13:29+00:00 0.0019 https://www.corporateprofile.com/2015/03/08/ 2026-09-27T04:13:29+00:00 0.0019 https://www.corporateprofile.com/2015/03/04/htbx-adding-monotherapy-hs-410-arm-to-current-phase-2-bladder-cancer-study/ 2015-03-04T21:04:10+00:00 0.0019 https://www.corporateprofile.com/2014/08/22/oramed-granted-patent-in-spain-for-oral-administration-of-insulin/feed/ 2026-09-27T04:13:29+00:00 0.0019 https://www.corporateprofile.com/2014/08/22/ds-healthcare-group-reports-second-quarter-2014-financial-results/feed/ 2026-09-27T04:13:29+00:00 0.0019 https://www.corporateprofile.com/2014/08/22/cel-sci-expands-its-global-phase-iii-trial-into-centre-hospitalier-universitaire-de-quebec-in-canada/feed/ 2026-09-27T04:13:29+00:00 0.0019 https://www.corporateprofile.com/2014/08/08/ds-healthcare-expands-distribution-channels-in-brazil-through-leading-rio-de-janeiro-pharmacy-chain/ 2014-08-08T18:16:15+00:00 0.0019 https://www.corporateprofile.com/2015/03/04/wafergen-announces-positive-results-of-a-single-cell-study-utilizing-its-smartchip-technology/feed/ 2026-09-27T04:13:29+00:00 0.0019 https://www.corporateprofile.com/2015/03/04/ 2026-09-27T04:13:29+00:00 0.0019 https://www.corporateprofile.com/2015/03/04/cvm-reports-2nd-month-of-record-patient-enrollment-in-15-for-phase-iii-cancer-trial/ 2015-03-04T18:12:23+00:00 0.0019 https://www.corporateprofile.com/2015/03/04/htbx-adding-monotherapy-hs-410-arm-to-current-phase-2-bladder-cancer-study/feed/ 2026-09-27T04:13:29+00:00 0.0015 https://www.corporateprofile.com/2015/03/04/pluristem-announces-significant-data-showing-plx-r18-cells-improve-bone-marrow-transplantation/ 2015-03-04T20:01:20+00:00 0.0015 https://www.corporateprofile.com/2014/08/08/ds-healthcare-expands-distribution-channels-in-brazil-through-leading-rio-de-janeiro-pharmacy-chain/feed/ 2026-09-27T04:13:29+00:00 0.0015 https://www.corporateprofile.com/2014/08/08/ 2026-09-27T04:13:29+00:00 0.0015 https://www.corporateprofile.com/2014/08/08/imsc-ceo-to-attend-inaugural-u-s-africa-business-forum-by-u-s-department-of-commerce/ 2014-08-08T17:54:51+00:00 0.0015 https://www.corporateprofile.com/2015/03/04/cvm-reports-2nd-month-of-record-patient-enrollment-in-15-for-phase-iii-cancer-trial/feed/ 2026-09-27T04:13:29+00:00 0.0015 https://www.corporateprofile.com/2015/03/04/pluristem-announces-significant-data-showing-plx-r18-cells-improve-bone-marrow-transplantation/feed/ 2026-09-27T04:13:29+00:00 0.0012 https://www.corporateprofile.com/2014/08/08/oramed-pharmaceuticals-reports-last-patient-out-in-phase-iia-trial-for-ormd-0801-in-type-1-diabetes/ 2014-08-08T16:32:10+00:00 0.0012 https://www.corporateprofile.com/2014/08/08/new-data-shows-high-efficacy-for-can-fites-cf101-in-rheumatoid-arthritis-and-psoriasis-patients/ 2014-08-08T15:49:25+00:00 0.0012 https://www.corporateprofile.com/2014/08/08/imsc-ceo-to-attend-inaugural-u-s-africa-business-forum-by-u-s-department-of-commerce/feed/ 2026-09-27T04:13:29+00:00 0.0012 https://www.corporateprofile.com/2014/08/08/oramed-pharmaceuticals-reports-last-patient-out-in-phase-iia-trial-for-ormd-0801-in-type-1-diabetes/feed/ 2026-09-27T04:13:29+00:00 0.0010 https://www.corporateprofile.com/2014/08/08/new-data-shows-high-efficacy-for-can-fites-cf101-in-rheumatoid-arthritis-and-psoriasis-patients/feed/ 2026-09-27T04:13:29+00:00 0.0010 https://www.corporateprofile.com/2014/08/05/future-rangers-hockey-101-at-city-ice-pavilion/ 2014-08-06T02:37:16+00:00 0.0010 https://www.corporateprofile.com/2014/08/05/future-rangers-hockey-101-at-city-ice-pavilion/feed/ 2026-09-27T04:13:29+00:00 0.0008 https://www.corporateprofile.com/2014/08/05/ 2026-09-27T04:13:29+00:00 0.0008 https://www.corporateprofile.com/2014/08/01/cel-sci-achieves-milestone-in-july-with-total-of-232-patients-enrolled/ 2014-08-01T19:15:50+00:00 0.0008 https://www.corporateprofile.com/2014/08/01/cel-sci-achieves-milestone-in-july-with-total-of-232-patients-enrolled/feed/ 2026-09-27T04:13:29+00:00 0.0006 https://www.corporateprofile.com/2014/08/01/ 2026-09-27T04:13:29+00:00 0.0006 https://www.corporateprofile.com/2014/08/01/israels-ministry-of-health-approves-psti-commercial-scale-3d-cell-manufacturing-process/ 2014-08-01T17:56:35+00:00 0.0006 https://www.corporateprofile.com/2014/08/01/france-becomes-17th-country-to-clear-cel-sci-for-patient-enrollment/ 2014-08-01T17:10:50+00:00 0.0005 https://www.corporateprofile.com/2014/08/01/israels-ministry-of-health-approves-psti-commercial-scale-3d-cell-manufacturing-process/feed/ 2026-09-27T04:13:29+00:00 0.0005 https://www.corporateprofile.com/2014/08/01/france-becomes-17th-country-to-clear-cel-sci-for-patient-enrollment/feed/ 2026-09-27T04:13:29+00:00 0.0004 https://www.corporateprofile.com/2014/07/28/can-fite-biopharma-ceo-dr-pnina-fishman-talks-about-the-role-of-cf101-in-treating-psoriasis/ 2014-07-28T20:40:29+00:00 0.0004 https://www.corporateprofile.com/2014/07/28/can-fite-biopharma-ceo-dr-pnina-fishman-talks-about-the-role-of-cf101-in-treating-psoriasis/feed/ 2026-09-27T04:13:29+00:00 0.0003 https://www.corporateprofile.com/2014/07/28/ 2026-09-27T04:13:29+00:00 0.0003 https://www.corporateprofile.com/2014/07/28/cel-sci-receives-regulatory-clearance-to-expand-phase-iii-head-and-neck-cancer-trial-into-turkey/ 2014-07-28T16:36:53+00:00 0.0003 https://www.corporateprofile.com/2014/07/28/cel-sci-receives-regulatory-clearance-to-expand-phase-iii-head-and-neck-cancer-trial-into-turkey/feed/ 2026-09-27T04:13:29+00:00 0.0003 https://www.corporateprofile.com/2014/07/18/ds-healthcare-opens-its-first-ds-laboratories-store-in-china/ 2014-07-18T20:39:50+00:00 0.0003 https://www.corporateprofile.com/2014/07/18/ds-healthcare-opens-its-first-ds-laboratories-store-in-china/feed/ 2026-09-27T04:13:29+00:00 0.0002 https://www.corporateprofile.com/2014/07/18/ 2026-09-27T04:13:29+00:00 0.0002 https://www.corporateprofile.com/2014/07/18/rnn-provides-update-on-phase-i-supinoxin-trial-in-cancer-patients-with-solid-tumors/ 2014-07-18T20:34:35+00:00 0.0002 https://www.corporateprofile.com/2014/07/18/imsc-ships-550000-in-explosives-trace-detectors-to-domestic-and-international-customers/ 2014-07-18T19:40:39+00:00 0.0002 https://www.corporateprofile.com/2014/07/18/cel-sci-expands-its-phase-iii-head-and-neck-cancer-trial-into-sri-lanka/ 2014-07-18T18:39:43+00:00 0.0002 https://www.corporateprofile.com/2014/07/18/cel-sci-receives-225000-nih-research-grant-to-develop-rheumatoid-arthritis-treatment/ 2014-07-18T18:22:26+00:00 0.0002 https://www.corporateprofile.com/2014/07/18/best-new-apps-for-nyc-urban-guidebook-tech-edition-2/ 2014-07-18T15:17:24+00:00 0.0002 https://www.corporateprofile.com/2014/07/18/rnn-provides-update-on-phase-i-supinoxin-trial-in-cancer-patients-with-solid-tumors/feed/ 2026-09-27T04:13:29+00:00 0.0002 https://www.corporateprofile.com/2014/07/18/imsc-ships-550000-in-explosives-trace-detectors-to-domestic-and-international-customers/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/18/cel-sci-expands-its-phase-iii-head-and-neck-cancer-trial-into-sri-lanka/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/18/cel-sci-receives-225000-nih-research-grant-to-develop-rheumatoid-arthritis-treatment/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/18/best-new-apps-for-nyc-urban-guidebook-tech-edition-2/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/11/cel-sci-presents-rheumatoid-arthritis-data-at-the-12th-vaccines-research-development-all-things-considered-conference/ 2014-07-11T20:12:53+00:00 0.0001 https://www.corporateprofile.com/2014/07/11/cel-sci-presents-rheumatoid-arthritis-data-at-the-12th-vaccines-research-development-all-things-considered-conference/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/11/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/11/can-fites-cf102-approved-for-compassionate-use-in-israel-for-liver-cancer-patient/ 2014-07-11T19:28:32+00:00 0.0001 https://www.corporateprofile.com/2014/07/11/blsp-receives-15000000-for-full-equity-financing-of-3-2-mw-rhode-island-biogas-project/ 2014-07-11T18:17:58+00:00 0.0001 https://www.corporateprofile.com/2014/07/11/borneos-gold-production-at-ratatotok-south-is-in-line-with-improved-extraction-rates/ 2014-07-11T17:38:12+00:00 0.0001 https://www.corporateprofile.com/2014/07/11/pluristem-initiates-south-korean-arm-of-multinational-phase-ii-intermittent-claudication-trial/ 2014-07-11T17:13:32+00:00 0.0001 https://www.corporateprofile.com/2014/07/11/can-fites-cf102-approved-for-compassionate-use-in-israel-for-liver-cancer-patient/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/11/blsp-receives-15000000-for-full-equity-financing-of-3-2-mw-rhode-island-biogas-project/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/11/borneos-gold-production-at-ratatotok-south-is-in-line-with-improved-extraction-rates/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/11/pluristem-initiates-south-korean-arm-of-multinational-phase-ii-intermittent-claudication-trial/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/pluristem-selects-rotator-cuff-repair-as-new-orthopedic-indication/ 2014-07-01T21:10:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/pluristem-selects-rotator-cuff-repair-as-new-orthopedic-indication/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/cel-sci-reports-93-increase-in-sequential-quarterly-patient-enrollment-in-its-phase-iii-cancer-trial/ 2014-07-01T20:50:40+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/imsc-ships-400000-in-explosives-trace-detectors-to-asia-europe-africa-and-middle-east/ 2014-07-01T20:27:21+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/american-association-of-airport-executives-ceo-todd-hauptli-visits-implant-sciences/ 2014-07-01T20:10:01+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/borneo-to-increase-gold-production-capacity-by-200-at-ratatotok-south-property/ 2014-07-01T20:01:54+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/blsp-signs-memorandum-of-understanding-to-build-3rd-waste-to-energy-project-in-massachusetts/ 2014-07-01T18:26:08+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/cel-sci-reports-93-increase-in-sequential-quarterly-patient-enrollment-in-its-phase-iii-cancer-trial/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/imsc-ships-400000-in-explosives-trace-detectors-to-asia-europe-africa-and-middle-east/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/american-association-of-airport-executives-ceo-todd-hauptli-visits-implant-sciences/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/borneo-to-increase-gold-production-capacity-by-200-at-ratatotok-south-property/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/07/01/blsp-signs-memorandum-of-understanding-to-build-3rd-waste-to-energy-project-in-massachusetts/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/06/19/can-fite-completes-patient-enrollment-in-its-phase-iiiii-psoriasis-trial/ 2014-06-19T20:49:16+00:00 0.0001 https://www.corporateprofile.com/2014/06/19/can-fite-completes-patient-enrollment-in-its-phase-iiiii-psoriasis-trial/feed/ 2026-09-27T04:13:29+00:00 0.0001 https://www.corporateprofile.com/2014/06/19/ 2026-09-27T04:13:29+00:00 0.0001